The stock index is gaining ground on Friday afternoon as investors look to reach a one-week high on Wall Street, largely optimistic about the prospect of a vaccine and treatment for Covid-1 for, while U.S. In the viral outbreak and ambush. Europe. Despite the lack of political momentum following the …
Read More »
Federal health regulators have ruled out a leading Covid-19 vaccine candidate from AstraZeneca AZN in the U.S. Allowed the study to resume. 0.08% According to a person familiar with the matter and content reviewed by Wall Street Journal, PLC and Oxford University. U.S. The Food and Drug Administration wrapped up …
Read More »
Mainz, Germany On a Friday in late January, Ugur Sahin received an email with bad news: A new study of a deadly new coronavirus in China suggests it is more contagious than previously thought. He believed the outbreak was likely to be an epidemic. The following Monday, the chief executive …
Read More »
Pfizer Inc. P.F.E. -0.84% Said it may be ready to apply for emergency-use authorization of its Covid-19 vaccine by the end of November, believing that in late-stage human trials will yield positive efficacy and safety data, the first time it or any other leading Western vaccine developer This kind of …
Read More »
File – This September 2020 photo, provided by Johnson & Johnson, shows a single-dose COVID-19 vaccine being developed by the company. A.P. European stocks held lower on Tuesday, with traders losing momentum after halting key coronavirus trials waiting for earnings from some of the world’s leading banks. Stocks Europe 600 …
Read More »